RESEARCH	O
DESIGN	O
AND	O
METHODS	O

For	O
this	O
study	O
,	O
20	O
individuals	O
(	O
mean	O
age	O
39	O
.	O
5	O
+	O
/	O
-	O
11	O
.	O
1	O
years	O
)	O
with	O
long	O
-	O
standing	O
type	O
1	O
diabetes	O
(	O
21	O
.	O
3	O
+	O
/	O
-	O
10	O
.	O
7	O
years	O
)	O
were	O
enrolled	O
in	O
this	O
prospective	O
open	O
-	O
label	O
crossover	O
trial	O
.	O

After	O
achieving	O
optimal	O
blood	B-Organism_substance
glucose	O
control	O
,	O
16	O
subjects	O
were	O
randomized	O
to	O
exenatide	O
with	O
or	O
without	O
daclizumab	O
.	O

Endogenous	O
insulin	O
production	O
was	O
determined	O
by	O
repeatedly	O
measuring	O
serum	B-Organism_substance
C	O
-	O
peptide	O
.	O

